Epidemiology
- Indications
- Renal Cell Cancer
Pharmacology
- xxx
Adverse Effects
- Pleural Effusion (see Pleural Effusion-Exudate)
- Acute Lung Injury-ARDS (see Acute Lung Injury-ARDS)
References
- Interleukin-2-induced lung injury. The role of complement. Circulation Research. 1994;74:329-335